Invasive Gastrointestinal Mucormycosis

Invasive mucormycosis is an opportunistic fungal infection that can be devastating in immunosuppressed patients. Gastrointestinal infection is rare, but carries among the highest mortality rates of its major clinical presentations. We present a case of invasive gastrointestinal mucormycosis in a pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Boris, Amundsen, Tyson, Farmer, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519550/
https://www.ncbi.nlm.nih.gov/pubmed/37753101
http://dx.doi.org/10.14309/crj.0000000000001161
_version_ 1785109724912418816
author Zhong, Boris
Amundsen, Tyson
Farmer, Christopher
author_facet Zhong, Boris
Amundsen, Tyson
Farmer, Christopher
author_sort Zhong, Boris
collection PubMed
description Invasive mucormycosis is an opportunistic fungal infection that can be devastating in immunosuppressed patients. Gastrointestinal infection is rare, but carries among the highest mortality rates of its major clinical presentations. We present a case of invasive gastrointestinal mucormycosis in a patient who underwent recent chemotherapy and autologous stem cell transplant. Initial histopathology revealed cytomegalovirus infection, which was treated before subsequent diagnosis of mucormycosis on repeat bowel biopsy. Our case highlights a myriad of risk factors that increase the potential for serious infection by this pervasive fungus.
format Online
Article
Text
id pubmed-10519550
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-105195502023-09-26 Invasive Gastrointestinal Mucormycosis Zhong, Boris Amundsen, Tyson Farmer, Christopher ACG Case Rep J Case Report Invasive mucormycosis is an opportunistic fungal infection that can be devastating in immunosuppressed patients. Gastrointestinal infection is rare, but carries among the highest mortality rates of its major clinical presentations. We present a case of invasive gastrointestinal mucormycosis in a patient who underwent recent chemotherapy and autologous stem cell transplant. Initial histopathology revealed cytomegalovirus infection, which was treated before subsequent diagnosis of mucormycosis on repeat bowel biopsy. Our case highlights a myriad of risk factors that increase the potential for serious infection by this pervasive fungus. Wolters Kluwer 2023-09-23 /pmc/articles/PMC10519550/ /pubmed/37753101 http://dx.doi.org/10.14309/crj.0000000000001161 Text en © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Zhong, Boris
Amundsen, Tyson
Farmer, Christopher
Invasive Gastrointestinal Mucormycosis
title Invasive Gastrointestinal Mucormycosis
title_full Invasive Gastrointestinal Mucormycosis
title_fullStr Invasive Gastrointestinal Mucormycosis
title_full_unstemmed Invasive Gastrointestinal Mucormycosis
title_short Invasive Gastrointestinal Mucormycosis
title_sort invasive gastrointestinal mucormycosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519550/
https://www.ncbi.nlm.nih.gov/pubmed/37753101
http://dx.doi.org/10.14309/crj.0000000000001161
work_keys_str_mv AT zhongboris invasivegastrointestinalmucormycosis
AT amundsentyson invasivegastrointestinalmucormycosis
AT farmerchristopher invasivegastrointestinalmucormycosis

Ejemplares similares